Prashant Gajwani, M.D., specializes in complex psychopharmacological management of bipolar disorder, treating depression and anxiety, and managing patients who require multiple medications from the classes of antipsychotics, anti-depressants, antiepileptic drugs and benzodiazepines. His research includes coexisting anxiety and substance use disorders in bipolar patients.
Scott Lane, Ph.D., specializes in substance use disorders, antisocial personality disorders, psychopharmacology, aggression, decision making, impulsivity and working memory.
Jennifer Reingle, Ph.D., specializes in criminal epidemiology, violent behavior, and intimate partner violence, as well as addiction and substance abuse. She can also discuss substance abuse in minority groups.
Previous interview: http://go.uth.edu/KERA_identity
Jennifer Sanner, Ph.D., M.S.N, R.N. specializes in genetic, depression, and women’s health research and is available to discuss the genetic link of heart disease, depression, and other conditions.
Previous Interview: http://bit.ly/Inro4c
Joy Schmitz, Ph.D., specializes in the treatment of substance use disorders using behavior therapy and pharmacotherapy. Her clinical research includes treatments for cocaine and major depression; smoking cessation; bipolar disorder and substance abuse; and alcohol abuse.
Previous Interview: http://bit.ly/IZ8des
Jair Soares, M.D., specializes in bipolar disorder, depression, brain imaging and psychopharmacology. His research includes discovering potential differences in the brains of people with bipolar disorder and the impact of pharmacological therapies on the brain using imaging.